Jiang, Ying <br/><br/>
Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.  [electronic resource] 

 -  International immunopharmacology  Dec 2019 
 - 105968 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2019.105968  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abietanes--pharmacology<br/>Animals<br/>Bleomycin--pharmacology<br/>Cell Line<br/>Disease Models, Animal<br/>Endothelial Cells--drug effects<br/>Endothelium--drug effects<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Female<br/>Fibrosis--drug therapy<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Mice<br/>Mice, Inbred C57BL<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Ribosomal Protein S6 Kinases, 70-kDa--metabolism<br/>Salvia miltiorrhiza--chemistry<br/>Scleroderma, Systemic--metabolism<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--metabolism